Size of this PNG preview of this SVG file: 512 × 402 pixels. Other resolutions: 306 × 240 pixels | 611 × 480 pixels | 978 × 768 pixels | 1,280 × 1,005 pixels | 2,560 × 2,010 pixels.
Original file (SVG file, nominally 512 × 402 pixels, file size: 654 KB)
Summary
| Description |
English: Immune checkpoints of inhibitory pathways are fundamental in the immune system to maintain self-tolerance and modulate immune responses. In breast cancer, some of these immune checkpoints and immunosuppressive factors have been associated with subtype specificity through their expressions on breast cancer cells. The different immune cells and their ligand-receptor interactions and secreted stimulatory growth factors, chemokines and cytokines are shown. The expression of these immune markers in the TME in breast cancer may or not be subtype-specific but are important in circumventing immune recognition or to immobilize effector T cells. Thus, the expression of these ligands and receptors may be associated with breast cancer stage and clinical outcome. (AKT. serine/threonine kinase or protein kinase B; ARG1. Arginase 1; Bcl-xL. B-cell lymphoma-xtra large; CAFs. Cancer-associated fibroblasts; CTLA4. cytotoxic T-lymphocyte-associated protein 4; ER− Estrogen Receptor Negative; GM-CSF. Granulocyte-Macrophage Colony-Stimulating Factor; HER2+. Human Epidermal Growth Factor Receptor 2; IDO. Indoleamine-2,3-dioxygenase; IFN-γ. interferon gamma; IFN-γR. interferon gamma receptor; IL. Interleukin; JAK. Janus kinase; iNOS. Inducible nitric oxide synthase; MDSC. Myeloid-derived suppressor cells; MHC. major histocompatibility complex; MMP. Matrix Metalloproteinases; mTOR. Mammalian target of rapamycin; MUC. Mucins; NK. natural killer; NF-κB. nuclear factor-κB; NLR. Neutrophil-lymphocyte ratio; NO. Nitric Oxide; PI3K. PI3K.phosphoinositide 3-kinase; PD-1. programmed death-1; PD-L1. Programmed death-ligand1; PGE2. Prostaglandin E2; PR−. Progesterone Receptor Negative; ROS. Reactive Oxygen Species; SHP. Src homology protein-tyrosine phosphatase; Siglec 9. Sialic acid-binding lectins 9; STAT. Signal transducer and activator of transcription; TAMs. Tumor-associated macrophages; TANs. Tumor-associated neutrophils; TGF-β. Transforming Growth Factor-beta; TIL. Tumor-Infiltrating Lymphocytes; TNBC. Triple Negative Breast Cancer; Treg. regulatory T cell; TCR. T cell receptor; VEGF. Vascular endothelial growth factor).[1] |
| Date | |
| Source | https://doi.org/10.3390/cancers11081205 |
| Author | Vanessa Barriga, Nyanbol Kuol, Kulmira Nurgali, and Vasso Apostolopoulos |
Licensing
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 20:20, 8 April 2020 | | 512 × 402 (654 KB) | Rob Hurt | Uploaded a work by Vanessa Barriga, Nyanbol Kuol, Kulmira Nurgali, and Vasso Apostolopoulos from https://doi.org/10.3390/cancers11081205 Add to Library with UploadWizard |
File usage
The following pages on the English Wikipedia use this file (pages on other projects are not listed):
Global file usage
The following other wikis use this file:
- Usage on bs.wikipedia.org
- Usage on fa.wikipedia.org
- Usage on fr.wikipedia.org
- Usage on ko.wikipedia.org
- Usage on zh-min-nan.wikipedia.org
